Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 8—August 2020
Research

Increased Sensitivity of Plasmodium falciparum to Artesunate/Amodiaquine Despite 14 Years as First-Line Malaria Treatment, Zanzibar

Mwinyi Msellem, Ulrika Morris, Aungpaing Soe, Faiza B. Abbas, Abdul-Wahid Ali, Rory Barnes, Paolo Frumento, Abdullah S. Ali, Andreas Mårtensson, and Anders BjörkmanComments to Author 
Author affiliations: Mnazi Mmoja Hospital, Zanzibar, Tanzania (M. Msellem); Karolinska Institutet, Stockholm, Sweden (U. Morris, A. Soe, R. Barnes, P. Frumento, A. Bjorkman); Zanzibar Malaria Elimination Programme, Zanzibar, Tanzania (F.B. Abbas, A.-W. Ali, A.S. Ali); Uppsala University, Uppsala, Sweden (A. Mårtensson)

Main Article

Table 3

Parasite clearance determined by microscopy in Plasmodium falciparum–positive persons, Zanzibar*

Characteristic Study group
2002–2003, n = 206 2005, n = 172 2017, all patients, n = 142 2017, age <5 y, n = 21 2017, parasite density >2,000/μL, n = 115
Parasite positivity by microscopy, no.; % (95% CI)
Day 0 206; 100 (98–100) 172; 100 (98–100) 142; 100 (97–100) 21; 100 (84–100) 115; 100 (97–100)
Day 1 137; 67 (60–73) 64; 37 (30–45) 58; 41 (33–49) 12; 41 (34–78) 53; 46 (37–56)
Day 2 18; 9 (5–13) 1; 0.6 (0–3) 2; 1 (0–5) 0; 0 (0–16) 1; 1 (0–5)
Day 3
1; 0.5 (0–3)
0; 0 (0–2)
1; 0.7 (0–4)
0; 0 (0–16)
0; 0 (0–3)
Geometric mean parasite density/µL for parasite-positive persons (range)
Day 0 19,858 
(2,000–198,447) 20,822 
(2,000–176,000) 7,899 
(75–304,000) 15,773 
(85–304,000) 14,305 
(2,175–304,000)
Day 1 359 (9–173,882) 397 (12–25,000) 822 (30–13,700) 802 (64–4,970) 83 (30–13,700)
Day 2 89 (32–552) 560, NA 500 (250–1,000) NA, NA 1,000, NA
Day 3 78, NA NA, NA 120, NA NA, NA NA, NA

*Values are proportions of patients positive by microscopy and with geometric mean parasite densities on days 0, 1, 2, and 3 after treatment. NA, not applicable.

Main Article

Page created: May 26, 2020
Page updated: July 17, 2020
Page reviewed: July 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external